Cargando…
Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
Enabling the early detection and prevention of diabetic kidney damage has potential to substantially reduce the global burden of kidney failure. There is a critical need for identification of mechanistic biomarkers that can predict progression and serve as therapeutic targets. In this issue of the J...
Autores principales: | Drexler, Yelena, Fornoni, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575719/ https://www.ncbi.nlm.nih.gov/pubmed/37843281 http://dx.doi.org/10.1172/JCI174015 |
Ejemplares similares
-
Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS
por: Mitrofanova, Alla, et al.
Publicado: (2020) -
Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022) -
Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
por: Njeim, Rachel, et al.
Publicado: (2023) -
New insights into renal lipid dysmetabolism in diabetic kidney disease
por: Mitrofanova, Alla, et al.
Publicado: (2021) -
Kidney health for all: bridging the gap in kidney health education and literacy
por: Langham, Robyn G., et al.
Publicado: (2022)